ÂÜÀòÂÒÂ×

Thomas Gegeny serves as the Director of Scientific Strategy & Partnerships at Prime since July 2021, where responsibilities include leading medical and scientific strategy for various clients and therapeutic areas, supporting new business expansion, and developing targeted innovations in medical communications. Prior to this role, Thomas was the Vice President and Portfolio Director at Envision Pharma Group from December 2015 to July 2021, focusing on scientific leadership for Medical Affairs activities. Thomas also held positions at Clear Pharma as Stakeholder Engagement Leader, and had a significant impact on HIV advocacy as Executive Director at The Center for AIDS Information & Advocacy. Educational qualifications include a Master's degree in Biomedical Sciences from The University of Texas Health Science Center at Houston and a Bachelor's degree in Biology from Fairfield University.